Dataset Information

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

ABSTRACT: Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to improve the efficacy of oncologic surgery. To achieve routine clinical use, the onus is on the surgical community to objectively assess the value of this technique. This assessment may facilitate both Food and Drug Administration approval of new optical imaging agents and reimbursement for the imaging procedures. It is critical to characterize fluorescence-guided procedural benefits over existing practices and to elucidate both the costs and the safety risks. This report is the result of a meeting of the International Society of Image Guided Surgery (www.isigs.org) on February 6, 2015, in Miami, Florida, and reflects a consensus of the participants' opinions. Our objective was to critically evaluate the imaging platform technology and optical imaging agents and to make recommendations for successful clinical trial development of this highly promising approach in oncologic surgery.

SUBMITTER: Rosenthal EL

PROVIDER: S-EPMC4772735 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

Rosenthal Eben L EL Warram Jason M JM de Boer Esther E Basilion James P JP Biel Merrill A MA Bogyo Matthew M Bouvet Michael M Brigman Brian E BE Colson Yolonda L YL DeMeester Steven R SR Gurtner Geoffrey C GC Ishizawa Takeaki T Jacobs Paula M PM Keereweer Stijn S Liao Joseph C JC Nguyen Quyen T QT Olson James M JM Paulsen Keith D KD Rieves Dwaine D Sumer Baran D BD Tweedle Michael F MF Vahrmeijer Alexander L AL Weichert Jamey P JP Wilson Brian C BC Zenn Michael R MR Zinn Kurt R KR van Dam Gooitzen M GM

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20151008 1

Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to improve the efficacy of oncologic surgery. To achieve routine clinical use, the onus is on the surgical community to objectively assess the value of this technique. This assessment may facilitate both Food and Drug Administration approval of new optical imaging agents and reimbursement for the imaging procedures. It is critical to characterize fluorescence-guided procedural benefits over existing prac ...[more]

PMID: 26449839

Similar Datasets

Project description:BackgroundIndicators to evaluate progress towards timely access to safe surgical, anaesthesia, and obstetric (SAO) care were proposed in 2015 by the Lancet Commission on Global Surgery. These aimed to capture access to surgery, surgical workforce, surgical volume, perioperative mortality rate, and catastrophic and impoverishing financial consequences of surgery. Despite being rapidly taken up by practitioners, data points from which to derive the indicators were not defined, limiting comparability across time or settings. We convened global experts to evaluate and explicitly define-for the first time-the indicators to improve comparability and support achievement of 2030 goals to improve access to safe affordable surgical and anaesthesia care globally.Methods and findingsThe Utstein process for developing and reporting guidelines through a consensus building process was followed. In-person discussions at a 2-day meeting were followed by an iterative process conducted by email and virtual group meetings until consensus was reached. The meeting was held between June 16 to 18, 2019; discussions continued until August 2020. Participants consisted of experts in surgery, anaesthesia, and obstetric care, data science, and health indicators from high-, middle-, and low-income countries. Considering each of the 6 indicators in turn, we refined overarching descriptions and agreed upon data points needed for construction of each indicator at current time (basic data points), and as each evolves over 2 to 5 (intermediate) and >5 year (full) time frames. We removed one of the original 6 indicators (one of 2 financial risk protection indicators was eliminated) and refined descriptions and defined data points required to construct the 5 remaining indicators: geospatial access, workforce, surgical volume, perioperative mortality, and catastrophic expenditure. A strength of the process was the number of people from global institutes and multilateral agencies involved in the collection and reporting of global health metrics; a limitation was the limited number of participants from low- or middle-income countries-who only made up 21% of the total attendees.ConclusionsTo track global progress towards timely access to quality SAO care, these indicators-at the basic level-should be implemented universally as soon as possible. Intermediate and full indicator sets should be achieved by all countries over time. Meanwhile, these evolutions can assist in the short term in developing national surgical plans and collecting more detailed data for research studies.

Dataset Information

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

Publications

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets